Telix gets pass-through status for Illuccix
Telix Pharmaceuticals has received transitional pass-through payment statu...Read more on AuntMinnie.comRelated Reading:
Monrol to supply Telix with Lu-177 for renal cancer trial
Telix touts rollout of Illuccix PSMA-PET radiotracer
Shine and Telix ink Lu-177 supply deal
Telix secures FDA clearance for prostate cancer PET imaging agent
Telix applauds NCCN radiotracer update
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | Kidney Cancer | Prostate Cancer | Radiology | Transitional Cell Carcinoma